CERo Therapeutics
Lola Shoaga is a highly skilled Senior Research Associate at CERo Therapeutics, Inc. since January 2022, and also serves as a Research Associate II in Vector Biology at BioMarin Pharmaceutical Inc. since February 2018. In this role, responsibilities include primer designs, animal studies, cloning, and conducting RNA/DNA analyses. Previous experience encompasses a Senior Analyst position at BioMarin, where cell line maintenance and qPCR methodologies for vector genome quantification were executed, as well as a contract role at Genentech, which involved microbial genome sequencing and bio-burden testing. Lola began their research career with an undergraduate internship at the University of California, Davis, focusing on the characterization of glucoside-hydrolase enzymes. Educational qualifications include a Bachelor of Science in Microbiology with a minor in Managerial Economics from the University of California, Davis, and an Associate's degree in Biology from Los Medanos College.
This person is not in any teams
CERo Therapeutics
CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that integrates innate and adaptive programs to eliminate disease.